Compare, Analyse Panacea Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs354373-   
Low Rs138269-   
Sales per share (Unadj.) Rs74.6111.1-  
Earnings per share (Unadj.) Rs6.7-28.0-  
Cash flow per share (Unadj.) Rs15.5-23.2-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs57.287.2-  
Shares outstanding (eoy) m61.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.9 114.0%   
Avg P/E ratio x36.8-11.5 -320.6%  
P/CF ratio (eoy) x15.9-13.9 -114.5%  
Price / Book Value ratio x4.33.7 116.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,06154,239 27.8%   
No. of employees `0002.34.3 53.9%   
Total wages/salary Rs m1,4713,404 43.2%   
Avg. sales/employee Rs Th1,973.64,366.6 45.2%   
Avg. wages/employee Rs Th635.6793.0 80.2%   
Avg. net profit/employee Rs Th176.8-1,100.3 -16.1%   
INCOME DATA
Net Sales Rs m4,56718,746 24.4%  
Other income Rs m45131 34.1%   
Total revenues Rs m4,61218,877 24.4%   
Gross profit Rs m2,030-3,249 -62.5%  
Depreciation Rs m540809 66.7%   
Interest Rs m1,048508 206.4%   
Profit before tax Rs m486-4,434 -11.0%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77277 27.8%   
Profit after tax Rs m409-4,724 -8.7%  
Gross profit margin %44.4-17.3 -256.5%  
Effective tax rate %15.9-6.2 -253.8%   
Net profit margin %9.0-25.2 -35.5%  
BALANCE SHEET DATA
Current assets Rs m2,41513,730 17.6%   
Current liabilities Rs m9,0777,725 117.5%   
Net working cap to sales %-145.932.0 -455.4%  
Current ratio x0.31.8 15.0%  
Inventory Days Days65111 58.7%  
Debtors Days Days71124 57.2%  
Net fixed assets Rs m8,3338,003 104.1%   
Share capital Rs m6187 70.4%   
"Free" reserves Rs m3,4430-   
Net worth Rs m3,50414,714 23.8%   
Long term debt Rs m4615,171 8.9%   
Total assets Rs m13,75527,795 49.5%  
Interest coverage x1.5-7.7 -18.9%   
Debt to equity ratio x0.10.4 37.5%  
Sales to assets ratio x0.30.7 49.2%   
Return on assets %10.6-15.2 -69.9%  
Return on equity %11.7-32.1 -36.4%  
Return on capital %38.7-19.8 -195.4%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Net fx Rs m7360-   
CASH FLOW
From Operations Rs m1,0491,600 65.5%  
From Investments Rs m-54-491 10.9%  
From Financial Activity Rs m-1,0114,693 -21.6%  
Net Cashflow Rs m-205,801 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.15 Rs / ZAR

Compare PANACEA BIOTECH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: DISHMAN PHARMA  ALKEM LABORATORIES  TTK HEALTHCARE  CADILA HEALTHCARE  GLENMARK PHARMA  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This... (Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun (Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel Views On News (Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PANACEA BIOTECH SHARE PRICE


Apr 13, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - CADILA HEALTHCARE COMPARISON

COMPARE PANACEA BIOTECH WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS